Circulating tumor DNA (ctDNA) is a promising biomarker for monitoring treatment response and progression-free survival in ...

Standard cancer screenings in the U.S. overlook nearly 70% of cancers and cancer subtypes. Multiple-cancer early detection (MCED) blood tests can help identify cancer biomarkers for multiple cancer ...

A team of researchers in California studied a new multi-cancer early detection test called Galleri, which can reportedly ...

Heal Squad' podcast host Maria Menounos, whose pancreatic cancer was discovered early enough to be treated, says, "If it ...

BERLIN -- Adding a test that predicts cancer signal origin to single standard of care (SoC) screening substantially increased ...

Teal Health is the first federally approved at-home cervical cancer screening. The Food and Drug Administration approved the ...

The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.

Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s ...

After surviving three types of cancer and having to face the harsh realities of colorectal and endometrial cancer and basal ...

After a rare cancer diagnosis, Maria Menounos is raising awareness about the power of outside screenings and being your own ...

Data at ESMO 2025 bolstered the case that blood tests could help doctors sort which patients need additional therapy, and who ...

An MCED blood test increased screenable cancer detection more than 7-fold when added to the US Preventive Services Task Force (USPSTF) A/B recommended screening.